Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia-Reference-Cited by-同舟云学术

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

Published:2013-07-11 Issue:2 Volume:122 Page:170-178
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Pession Andrea¹,Masetti Riccardo¹,Rizzari Carmelo²,Putti Maria Caterina³,Casale Fiorina⁴,Fagioli Franca⁵,Luciani Matteo⁶,Lo Nigro Luca⁷,Menna Giuseppe⁸,Micalizzi Concetta⁹,Santoro Nicola¹⁰,Testi Anna Maria¹¹,Zecca Marco¹²,Biondi Andrea²,Pigazzi Martina³,Rutella Sergio⁶,Rondelli Roberto¹,Basso Giuseppe³,Locatelli Franco⁶¹³

Affiliation:

1. Clinica Pediatrica, Università di Bologna, Ospedale “S. Orsola,” Bologna, Italy;

2. Clinica Pediatrica, Università di Milano-Bicocca, Fondazione MBBM, Ospedale S. Gerardo, Monza, Italy;

3. Clinica Oncoematologia Pediatrica, Università di Padova, Padova, Italy;

4. Clinica Pediatrica, I Policlinico, II Università di Napoli, Napoli, Italy;

5. Oncoematologia Pediatrica, Ospedale Infantile “Regina Margherita,” Torino, Italy;

6. Oncoematologia Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy;

7. Oncoematologia Pediatrica, Azienda Policlinico OVE, Catania, Italy;

8. Oncoematologia Pediatrica, Ospedale Pausillipon, Napoli, Italy,

9. Oncoematologia Pediatrica, IRCCS Istituto “Giannina Gaslini,” Genova, Italy;

10. Clinica Pediatrica, Policlinico di Bari, Bari, Italy;

11. Sezione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Università “Sapienza,” Roma, Italy;

12. Oncoematologia Pediatrica, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; and

13. Department of Pediatrics, Università di Pavia, Pavia, Italy

Abstract

Key Points Risk-adapted therapy and broad use of HSCT resulted in a significant improvement in outcome. AUTO- or ALLO-HSCT in high-risk patients resulted in a cumulative incidence of leukemia relapse superimposable to that of SR.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/2/170/1371391/170.pdf

Reference49 articles.

1. Biology, risk stratification, and therapy of pediatric acute leukemias: an update.;Pui;J Clin Oncol,2011

2. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.;Kaspers;Haematologica,2007

3. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.;Creutzig;Blood,2012

4. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.;Pession;Leukemia,2005

5. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.;Creutzig;Leukemia,2005

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival outcome of childhood acute myeloid leukemia: a 43-year experience in Thailand, a resource-limited country;Leukemia & Lymphoma;2024-07-26

2. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

3. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia;Blood Advances;2024-06-14

4. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study;Pediatric Blood & Cancer;2024-04-14

5. The prognosis of haploidentical hematopoietic stem cell transplantation in infants and patients under 3 years old with acute leukemia;Clinical Transplantation;2024-02